Loading, please wait ...


News Analytics

e21256d2e03cc899c7bd511104087cadb7c3350f 356x200 jpg?fit=crop&auto=format.
Accordingly, findings presented at the 2021 American Urological Association Annual Meeting showed early promise with neoadjuvant 177Lu-PSMA imaging and therapy in patients with locally advanced, high-risk disease.1 Specifically, 177Lu-PSMA imaging and therapy followed by radical prostatectomy exhibited a favorable safety profile and early signs of efficacy.

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions